Have you been looking for a drug handbook written especially for nurses caring for patients with cancer? We just published 2018 Oncology Nursing Drug Handbook by Gail M. Wilkes and Margaret Barton-Burke. Updated annually, it uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation.
- Provides valuable information on effective symptom management, patient education, and chemotherapy administration
- Includes separate chapters on molecular and immunologic/biologic targeted therapies that provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
New Drugs Include:
avelumab (Bavencio), brigatinib (Alunbrig), durvalumab (Imfinzi), enasidenib (Idhifa), metronidazole hydrochloride (Flagyl), midostaurin (Rydapt), neratinib (Nerlynx), niraparib (Zejula), olaratumab (Lartruvo), ribociclib (Kisqali), rituximab and hyaluronidase human injection (Rituxan Hycela injection), rucaparib (Rubraca), telotristat ethyl (Xermelo), and tisagenlecleucel (Kymriah)
Learn more at our website.